Northwire Canada EditionTuesday, August 25, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0% GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0%
Regulatory Neutral

GuideAI Health Corp. to Begin Trading on Cboe Canada Under the Symbol "GDAI"

AI-driven vascular disease detection moves to public markets, but execution and commercialization remain unproven.

By The Northwire Desk — AI Analysis Jun 29, 2026 · 08:00 GDAI NaN
Executive Summary
  • GuideAI Health Corp. has received final approval from Cboe Canada Inc. to list its common shares on the Cboe Canada exchange.
  • Trading under the ticker symbol "GDAI" is scheduled to commence at market open on June 29, 2026.
  • The company operates in healthcare technology, utilizing artificial intelligence to analyze routine CT scans for the early detection of peripheral vascular disease.
  • Management frames the listing as a milestone to scale the platform and expand access to diagnostic technology.
Material Impact
  • The announcement is a standard administrative and regulatory step for a company transitioning to or expanding its public market access.
  • No concurrent capital raise, valuation metrics, institutional anchor investors, or financial disclosures are included in the release.
  • Without details on share count, offering price, or immediate liquidity provisions, the listing itself does not alter the company's fundamental valuation or cash position.
  • The primary material impact is procedural: increased visibility, potential future access to public capital markets, and standard exchange compliance requirements.
GDAI · Price
Company Overview
  • GuideAI Health Corp. is a healthcare technology firm focused on artificial intelligence applications in medical imaging.
  • Core product: AI algorithms that analyze routine CT scans to identify peripheral vascular disease.
  • Target customers: Hospitals and radiology groups seeking earlier detection and more precise treatment planning.
  • Current stage: Pre-listing/pre-commercialization phase with no disclosed revenue or proven market penetration.
Read the original news release →